CAS: 51-12-7; Nialamide

该化合物是一种化学化合物,被归类为单胺氧化酶抑制剂(MAOI),主要用于治疗抑郁,其特点是它能够抑制酶-单胺氧化酶,该酶在诸如Serotonin, norepinephinerin和多巴胺等...

结构式图片

欧盟法规

ECHA物质C&L通报REACH预注册

合成工艺路线路线简述

    📜,无水乙酸钠,溴化乙啶,,氯化钠,,,,2-环戊烯-1-羧酸,3-异丙基-1-甲基-(5Ci) 以 Sodium Hydroxide,三羟甲基氨基甲烷盐酸盐 作为反应溶剂,化学反应 1.0H,反应生成 尼亚酰铵
    参考文献:Methods Of Forming Circular Nucleic Acid Probes And Uses Thereof
    标题:Methods Of Forming Circular Nucleic Acid Probes And Uses Thereof
    摘要:本发明通常涉及一种通过滚动环形扩增法扩增闭合环状核酸探针的方法,特别是涉及一种扩增闭合环状核酸探针的方法.本发明的方法在涉及检测核酸序列的各种应用中有用,例如但不限于鉴定遗传疾病,基因变异或微生物或病毒代理的存在.

    海关参考信息

    专利信息


    专利号:US-7576211-B2
    优先权日:2004-09-30
    标题 :Synthesis of thienopyridinone compounds and related intermediates
    发明人:DHANOA DALE S; BECKER OREN; NOIMAN SILVIA; CHEN DONGLI; MARANTZ YAEL; SHACHAM SHARON; HEIFETZ ALEXANDER; INBAL BOAZ; BAR-HAIM SHAY; MOHANTY PRADYUMNA; LOBERA MERCEDES; WU LAURENCE
    权利人:EPIX DELAWARE INC
    摘要:The invention relates to 5-HT receptor agonists and partial agonists. Novel thienopyridinone compounds represented by Formula I, and synthesis and uses thereof for treating diseases mediated directly or indirectly by 5-HT receptors, are disclosed. Such conditions include Alzheimer's disease, cognition disorders, irritable bowel syndrome, nausea, emesis, vomiting, prokinesia, gastroesophageal reflux disease, nonulcer dyspepsia, depression, anxiety, urinary incontinence, migraine, arrhythmia, atrial fibrillation, ischemic stroke, gastritis, gastric emptying disorders, feeding disorders, gastrointestinal disorders, constipation, erectile dysfunction, and respiratory depression. Methods of preparation and novel intermediates and pharmaceutical salts thereof are also included.

    专利号:US-4310535-A
    优先权日:1976-11-30
    标题:Combination of drugs and a method for the selective control of the immune reactions evoked in a host by the administration of antigens
    发明人:PIERPAOLI WALTER
    权利人:PIERPAOLI WALTER
    摘要:The invention concerns a new composition or combination of drugs effective to selectively control the immune reactions which are evoked in a host by the administration of antigens. It comprises active components capable of simultaneously blocking the alpha -adrenergic receptors of the cells for catecholamine, blocking the dopaminergic receptors of the cells and increasing the synthesis of serotonin. Preferred drug combinations according to the invention contain in association phentolamine, haloperidol, L-5-hydroxy-tryptophane and possibly dopamine.

    专利号:US-2008214827-A1
    优先权日:2004-02-03
    标 题:Synthesis of Cyanoimino-Benzoimidazoles
    发明人:GOEHRING R RICHARD; WHITEHEAD JOHN; SHAO BIN
    权利人:EURO CELTIQUE SA
    摘要:Disclosed in certain embodiments is a process for synthesizing a compound of formula (V) and salts thereof.

    专利号:US-11408016-B2
    优先权日:2018-12-28
    标 题:Amino acid dehydrogenase mutant and application in synthesis of L-glufosinate-ammonium thereof
    发明人:XUE YAPING; CHENG FENG; LI HENG; ZHENG YUGUO; XU JIANMIAO
    权利人:UNIV ZHEJIANG TECHNOLOGY
    摘要:The present invention discloses an amino acid dehydrogenase mutant and application thereof in synthesizing L-glufosinate-ammonium, the amino acid dehydrogenase mutant is obtained by a single mutation or a multi-site mutation of the amino acid at position 95, 108, 172, 303 of the amino acid sequence shown in SEQ ID No. 2. The amino acid dehydrogenase mutant DyGDH-F95I-A108T-R172P-R303H prepared by the present invention has a specific enzyme activity that is 33 times higher than that of the original Aldo-keto reductase, and the concentration of the largest substrate, 2-carbonyl-4-(hydroxymethylphosphinyl)-butyric acid reaches 500 mM, the amino acid dehydrogenase mutant has more industrial application prospects. Using the amino acid dehydrogenase mutant to produce L-glufosinate-ammonium, the reaction time is significantly shortened, the general process takes 20 hours, and the reaction time of the present invention only requires 120 minutes, which shows that the amino acid dehydrogenase mutant has a good industrial application prospect.

    专利号:US-2024287479-A1
    优先权日:2021-08-23
    标 题 :Glycosyltransferase mutant, and method for catalytic synthesis of rebaudioside m using glycosyltransferase mutant

    专利号:US-2006084805-A1
    优先权日:2004-09-30
    标题:Synthesis of thienopyridinone compounds and related intermediates

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献


    1: Domínguez-Rodríguez LE, Stecina K, García-Ramírez DL, Mena-Avila E, Milla- Cruz JJ, Martínez-Silva L, Zhang M, Hultborn H, Quevedo JN. Candidate Interneurons Mediating the Resetting of the Locomotor Rhythm by Extensor Group I Afferents in the Cat. Neuroscience. 2020 Dec 1;450:96-112. doi: 10.1016/j.neuroscience.2020.09.017. Epub 2020 Sep 15. 57(2):937-948. doi: 10.1007/s12035-019-01788-2. Epub 2019 Oct 15.
    3: Wang BS, Liu Z, Sun SL, Zhao Y. Identification of genes and candidate agents associated with pancreatic cancer. Tumour Biol. 2014 Jan;35(1):81-8. doi: 10.1007/s13277-013-1009-3. Epub 2013 Aug 10. 17(7):957-65. doi: 10.1177/1087057112444927. Epub 2012 Apr 24. 590(2):289-300. doi: 10.1113/jphysiol.2011.214643. Epub 2011 Nov 21.
    6: Fuxe K, Dahlström AB, Jonsson G, Marcellino D, Guescini M, Dam M, Manger P, Agnati L. The discovery of central monoamine neurons gave volume transmission to the wired brain. Prog Neurobiol. 2010 Feb 9;90(2):82-100. doi: 10.1016/j.pneurobio.2009.10.012. Epub 2009 Oct 21. 877(3):285-90. doi: 10.1016/j.jchromb.2008.12.024. Epub 2008 Dec 24.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知